Medikinet

Methylphenidate Hydrochloride, the active ingredient in Medikinet, is a central nervous system stimulant presented as a tablet for oral use. It treats attention deficit hyperactivity disorder (ADHD) and narcolepsy in children, adolescents, and adults.

GNH USA supplies Medikinet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide, adhering to WHO GMP guidelines and providing regulatory support for import and distribution. Our global logistics network ensures timely delivery and product integrity across EU and other markets.

Methylphenidate acts on central nervous system pathways involved in attention and wakefulness.

- Attention deficit hyperactivity disorder (ADHD): improves concentration, reduces hyperactivity and impulsivity. - Narcolepsy: decreases excessive daytime sleepiness and improves wakefulness. - ADHD in adults: enhances daily functioning and occupational performance.

Methylphenidate may cause a range of adverse reactions.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced hunger leading to weight loss. - Headache: mild to moderate cranial pain. - Stomach pain: abdominal discomfort or nausea. - Increased heart rate: tachycardia or palpitations. - Anxiety: heightened nervousness or restlessness.

Serious or Rare Side Effects: - Cardiovascular events: hypertension, arrhythmia, or myocardial infarction. - Psychosis: hallucinations or delusional thinking. - Seizures: convulsive episodes in susceptible individuals. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Priapism: prolonged painful erection requiring medical attention. - Growth suppression: reduced height velocity in children with prolonged use.

Methylphenidate requires careful assessment before and during therapy.

- Cardiovascular evaluation: screen for heart disease, hypertension, or arrhythmias before initiating treatment. - Psychiatric monitoring: observe for worsening anxiety, depression, or emergence of psychotic symptoms. - Growth monitoring: regularly measure height and weight in pediatric patients. - Abuse potential: prescribe only when benefits outweigh risks and educate about misuse. - Drug interactions: avoid concurrent use with MAO inhibitors or other stimulants. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Methylphenidate can interact with several medicines.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Other central nervous system stimulants: additive cardiovascular and CNS effects. - Certain antihypertensive agents: may reduce blood pressure control.

Moderate Interactions (Monitor Closely):\n- Selective serotonin reuptake inhibitors (SSRIs): possible increase in serotonin levels. - Antacids: may affect absorption of the drug. - Alcohol: can exacerbate CNS stimulation and cardiovascular side effects. - Antipsychotics: may diminish therapeutic efficacy of methylphenidate.